Brett Kaplan

Brett Kaplan is recorded as CFO at Climb Bio, Inc. (CLYM) since August 26, 2024 and COO at Climb Bio, Inc. (CLYM). The newest filing on record that lists Brett Kaplan as COO at Climb Bio, Inc. (CLYM) is dated April 25, 2025. Earlier roles on record: Board Member at Compass Therapeutics, Inc. (CMPX) until February 25, 2022. Climb Bio, Inc. reported in an 8-K filed August 27, 2024 that Brett Kaplan was appointed principal financial officer, effective August 26, 2024. Climb Bio, Inc. reported in an 8-K filed August 26, 2024 that Brett Kaplan was appointed Chief Operating Officer, effective August 26, 2024. The proxy statement of Climb Bio, Inc. reports total compensation of $1,161,728 for Brett Kaplan in fiscal 2025, including a base salary of $223,608. Disclosed compensation is on record for 2 fiscal years. Climb Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Climb Bio, Inc. includes Aoife Brennan (CEO, CFO and Board Member), Aoife Brennan, M.B., Ch.B. (CEO and Board Member), Dr. Stephen Thomas (CEO) and 7 others.